•
Jun 30, 2018

Voyager Therapeutics Q2 2018 Earnings Report

Total Revenue
$2.58M
Previous year: $1.18M
+118.8%
EPS
-$0.8
Previous year: -$0.73
+9.6%
Gross Profit
-$13.9M
Cash and Equivalents
$59.6M
Free Cash Flow
-$23.8M
Total Assets
$215M

Voyager Therapeutics

Voyager Therapeutics